Company / Financials
Pacira BioSciences, Inc. Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$726.4M
FY2025 · +3.6% YoY
Net Income
$7.0M
FY2025 · +107.1% YoY
Profit Margin
1.0%
FY2025 · net income / revenue
ROE
1.0%
FY2025 · return on equity
Total Assets
$1.3B
FY2025
Total Debt
$372.2M
0.54x debt/equity
Equity
$693.1M
FY2025
ROA
0.6%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$726.4M+3.6% YoYNet Income HistoryProfit after all expenses and taxes$7.0M+107.1% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$149.7M-12.1% YoYOperating Income HistoryProfit from core business operations before interest and taxes$19.2M+126.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$368.8M+25.4% YoYR&D Expense HistoryResearch and development spending$117.3M+43.8% YoYInterest Expense HistoryCost of borrowing and debt obligations$17.4M+5.3% YoYIncome Tax HistoryTotal income tax expense$9.8M-73.0% YoYEPS (Basic) HistoryBasic earnings per share$0.91+142.3% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$0.89+141.4% YoY